Cyberonics , Obesity-Related Patents

Dec. 18, 2008 - Cyberonics, Inc. (Nasdaq: CYBX) announced that effective December 18, 2007, the company has entered into an agreement with Ethicon Endo-Surgery granting exclusive rights to the company's patents and patent applications pertaining to vagus nerve stimulation (VNS) for the treatment of obesity and two related co-morbidities, diabetes and hypertension, in overweight patients... Cyberonics' Press Release-

Ethicon Endo-Surgery, REALIZE™ Adjustable Gastric Band For Morbid Obesity

September 28, 2007– Ethicon Endo-Surgery, Inc. announced the U.S. Food and Drug Administration (FDA) approved for marketing the REALIZE™ Adjustable Gastric Band, a surgical implant for weight reduction and improvement in obesity-related health conditions, such as type-2 diabetes, in individuals suffering from morbid obesity... Ethicon's Press Release -